Peptilogics is an early-stage biotechnology company utilizing an innovative platform technology which enables us to rapidly and effectively develop novel peptide therapeutics, with a focus on antibiotics. Our pipeline includes a novel class of engineered Cationic Antimicrobial Peptides (eCAPs).
